Rock Springs Capital Management LP 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:10 am Purchase |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Rock Springs Capital Management LP | 4,973,649 5.720% |
561,666 (+12.73%) |
Filing |
| 2024-05-01 4:11 pm Purchase |
2024-04-25 | 13G | Travere Therapeutics, Inc. TVTX |
Rock Springs Capital Management LP | 4,411,983 5.790% |
4,411,983 (New Position) |
Filing |